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ABSTRACT
Objective: To evaluate disorder of sex development (DSD) profile at Cipto Mangunkusumo Hospital (RSCM), the 
management profile, and the role of urologist on diagnostic and therapeutic management. Material & method: We 
retrospectively collected data from medical record of all DSD cases managed by pediatric endocrinologist, urologist, 
obstetric gynaecologist at RSCM from January 2002 up to December 2009. 2006 IICP criteria was used as classification. 
The management profile and the role of urologist were evaluated. Results: there were 133 DSD cases with the majority of 
cases was congenital adrenal hyperplasia (CAH) followed by androgen insensitivity syndrome (AIS). Most of the cases were 
diagnosed before one year old and other on pubertal period. Karyotyping, laboratory examination, ultrasonography, 
genitography, uretrocystoscopy, kolposcopy, diagnostic laparascopy were performed as diagnostic management. Gender 
assignment was performed by multidisciplinary team. Masculinizing surgery, feminizing surgery, and gonadectomy was 
done as therapeutic management. Conclusion: The majority case on RSCM's DSD profile was CAH. The management was 
performed by multidisciplinary team. Gender assignment decision should be based upon thorough diagnostic evaluation. 
The urologist has important role on diagnostic and therapeutic management.
Keywords: Disorder of sex development, diagnostic management, gender assignment, therapeutic management, urologist.
ABSTRAK
Tujuan Penelitian: Mengetahui gambaran kasus disorder of sex development (DSD), alur penanganan kasus serta peran 
ahli urologi dalam tatalaksana diagnosis dan terapeutik DSD di RSUPN Cipto Mangunkusumo (RSCM) Jakarta. Bahan & 
Cara: Kami melakukan penelitian deskriptif retrospektif terhadap data yang diperoleh dari rekam medis kasus yang 
ditangani oleh tim endokrinologi anak, urologi, dan kebidanan RSCM dalam periode Januari 2002 sampai dengan 
Desember 2009. Kriteria IICP 2006 digunakan sebagai klasifikasi kelompok DSD. Alur penanganan kasus dan peran ahli 
urologi dievaluasi. Hasil Penelitian: Terdapat 133 kasus DSD selama periode penelitian, kasus congenital adrenal 
hyperplasia (CAH) merupakan kasus tersering yang ditemukan diikuti kasus androgen insensitivity syndrome (AIS). 
Sebagian kasus didiagnosis saat usia bayi dan sebagiannya lagi saat usia pubertal. Telah dilakukan sejumlah upaya 
diagnostik meliputi analisa kariotipe, pemeriksaan laboratorium, ultrasonografi, genitografi, uretrosistoskopi-kolposkopi, 
laparaskopi diagnostik. Gender assignment dilakukan dengan melibatkan tim multidiplin. Jenis operasi yang telah 
dilakukan meliputi masculinizing surgery, feminizing surgery, dan gonadektomi. Simpulan: Gambaran kasus DSD di 
RSCM sebagian besar merupakan kasus CAH. Alur penatalaksanaan kasus DSD telah melibatkan tim multidisiplin. Upaya 
diagnostik yang menyeluruh penting dilakukan sebelum gender assignment dilakukan. Ahli urologi berperan penting dalam 
upaya diagnostik dan upaya terapeutik. 
Kata Kunci: Disorder of sex development, upaya diagnostik, gender assignment, upaya terapeutik, ahli urologi.
Correspondence: Ilham Wahyudi Masfar, c/o: Department of Urology, Faculty of Medicine/Indonesia University, Cipto Mangunkusumo 
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INTRODUCTION
Disorder of sex development (DSD) is a 
congenital abnormality characterized by the 
incompatibility between the sex chromosome, 
1gonads, or the sex phenotype.  It is a rare 
abnormality with the estimated incidence of 1 in 
2every 2.000 live births.  Others reported the 
3incidence of 1 in every 4500 live births.  The 
abnormality can be diagnosed during infancy or 
during adulthood. 
The classification of DSD is still varied along 
with the development of science and understanding 
about the disease. One of the classification proposed 
by The International Intersex Consensus 
Conference Participant (IICCP) in 2006 is as 
follows.
The main objective of the management of DSD 
is to establish a diagnosis, to make gender 
assignment when necessary, and to initiate therapy 
4as soon as possible.  The DSD management 
encompasses diagnostic and therapeutic 
management. The diagnostic efforts include the 
physical examination, laboratory examination, 
chromosome analysis, diagnostic radiology and 
diagnostic laparoscopy. The therapeutic efforts 
include gender assignment, medication, surgery, and 
5psychosexual therapy.  Some of the concerns of the 
objectives of DSD management are reproduction 
potentials, sexual potentials, minimally-invasive 
surgery, a gender appropriate physical appearance, a 
consistent gender identity, and a satisfying 
1psychosocial sentiment.
The management of DSD should be carried out 
by a multidisciplinary team working together in a 
tertiary institution. The team should include an 
endocrinologist, urologist, geneticist, gynecologist, 
4and a psychiatrist.  This multidisciplinary team 
should always consists of a urologist. Usually, the 
urologist becomes the first line consultant, especially 
4in an institution without a multidisciplinary team.
The urologist plays a role in the diagnostic and 
therapeutic management.  The diagnostic 
management conducted by urologists are anamnesis, 
physical examination including the one conducted 
under anesthesia, laboratory examination and 
Table 1. DSD Classification proposed by IICCP 2006.   
Sex Chromosome DSD 46 XY DSD 46 XX DSD
A. 45,X0 (turner syndrome and 
variants)  
A. Disorder of gonadal development  
1.  Complete gonadal dysgenesis  
(swyer syndrome)  
2.  Partial gonadal dysgenesis  
3.  Gonadal regresion  
4.  Ovotesticular DSD  
A. Disorder of gonadal             
development  
1.  Ovotesticular DSD  
2.  Testicular DSD  
(SRY+)  
3.  Gonadal dysgenesis  
B.  47XXY (klinefelter syndrome 
and variants)  
B.  Disorder in androgen syntesis or 
action  
1.  Androgen biosyntesis defect  
(eg. 5 a reductase deficiency)  
2.  Defect in androgen action  (eg.  
complete/partial androgen 
insensivity syndrome 
(CAIS/PAIS))  
3.  LH reseptor defect  (leydig cell 
hypoplasia/aplasia)  
4.  Disorder of AMH or AMH 
receptor  (persistent mullerian 
duct syndrome)  
B. Androgen excess  
1.  Fetal  (Congenital 
adrenal hyperplasia 
(CAH))  
2.  Fetoplacental  
(aromatase 
deficiency,  POR)  
3.  Maternal  (luteoma)  
C.  45X/46XY  (mixed gonadal 
dysgenesis,  ovotesticular DSD)  
C. Other  (severe hipospadia, cloaka 
extrophy,  aphalia)  
C. Other  (cloaka extrophy,  
vaginal agenesis)  
D. 46XX/46XY  (chimeric,  
ovotesticular DSD)
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chromosome analysis, imaging with ultrasono-
graphy, genitography, uretrocystoscopy and 
6laparoscopy.  The therapeutic management which 
can be conducted by the urologists are masculinizing 
surgery, feminizing surgery, and gonadectomy.
OBJECTIVE
To evaluate the case profile of DSD in RSCM, 
the case management, and the role of urologist in the 
management of diagnosis and therapy of DSD in 
RSCM.
MATERIAL & METHOD
We conducted a retrospective descriptive study 
using the medical records data of the cases handled 
by the pediatric endocrinology, urology and 
obstetrics and gynecology team of RSUPN Dr. Cipto 
Mangunkusumo during the period of January 2002 
to December 2009. The data collection included the 
type of DSD, the patients' age, sex of rearing (the 
type of rearing based on certain gender), diagnostic 
efforts, gender assignment (the gender of choice 
based on mutual consensus) and the type of 
Table 2. Frequency and percentage of each DSD type and its classification based on IICCP 2006* 
therapeutic effort which will be conducted.
The DSD type is established from the findings in 
physical, laboratory and karyotype examination. 
Afterwards, the data will be classified based on the 
classification of 2006 IICP. The existing data is 
processed using SPSS v 17.0.
RESULTS
During the period of January 2002 to December 
2009, the multidisciplinary team of RSUPN Cipto 
Mangunkusumo had managed 133 DSD cases. The 
number and percentage of each type of DSD cases and 
its classification according to the 2006 IICP can be 
seen in table 2.
The age of the patient at the time of the diagnosis 
is divided into four age groups, infant (1 year old), 
toddlers (1-5 years old), prepubertal (6-10 years old) 
and pubertal (> 11 years old), which can be observed 
in table 3, and sex of rearing can be seen in table 4.
Genitography, uretrocystoscopy-colposcopy, and 
diagnostic laparoscopy are carried out as diagnostic 
management. The genitography is performed by a 
radiology team, while the uretrocystoscopy-
colposcopy and diagnostic laparoscopy is performed 
by the urologist team. The numbers of each diagnostic 
management can be seen in table 5.
 *not included severe hypospadia and cloaca extrophy cases
1 Mixed gonadal dysgenesis
2 Androgen insensitivity syndrome
3 Congenital adrenal hyperplasia
DSD Type Frequency Percentage 
Sex chromosome DSD Turner syndrome 15 11,3 
MGD1 9 6,8 
46 XY DSD AIS2 18 13,5 
5 alpha reduktase deficiency 4 3,0
 Aphalia 1 0,8 
Gonadal dysgenesis 1 0,8
46 XX DSD Ovotesticular 3 2,3 
CAH3 75 56,4 
Vaginal atresia 2 1,5
Not yet underwent full workup 5 3,8
Total 133 100 
14
Table 3.  Distribution of age at diagnose and management of each DSD types. 
1 2 3Mixed gonadal dysgenesis  Androgen insensitivity syndrome  Congenital adrenal hyperplasia
Table 4. Sex of rearing of each DSD types.
Tabel 5. Additional examination.
During the diagnostic laparoscopy, the team 
evaluates the structure of internal genitalia which 
derives from the Mullerian structure and the 
structure of gonads. A biopsy can also be performed 
during this procedure. The biopsy results which was 
obtained in this study reported 3 cases showing 
testes and gonad streak, 1 case showing ovaries and 
testes, 1 case showing ovotestes, and 1 case showing  
prepubertal testes with gonadoblastoma testicular 
dysplasia.
After all of the data had been collected, the 
multidisciplinary team conducted a gender 
assignment by a conference involving the patients 
and the family. The results of gender assignment of 
the 133 DSD cases can be seen on table 6.
The therapeutic management of DSD includes 
medication and surgery. The types of surgery for 
these cases are masculinizing genitoplasty, 
Age Classification 
Infant 
(< 1 yrs) 
Toddler 
(2-5 yrs 
Prapubertal 
(6-10 yrs) 
Pubertal 
(> 11 yrs) Total
Turner syndrome 0 0 1 14 15 Sex chromosome DSD 
MGD1 2 4 1 2 9 
46 XY DSD AIS2 0 1 0 0 1 
5 alpha reduktase deficiency 0 0 1 3 4 
Aphalia 6 5 1 6 18 
Gonadal dysgenesis 1 0 0 0 1
46 XX DSD Ovotesticular 1 1 0 1 3
CAH3 50 15 7 3 75
Vaginal atresia 0 0 0 2 2
Not yet underwent full workup 4 1 0 0 5 
Total 64 27 11 31 133
Sexofrearing
Male Female Total
Sex chromosome DSD 2 22 24
46XYDSD 15 9 24 
46XXDSD 13 67 80 
Type 
Not yet underwent full workup 3 2 5 
Total 33 100 133
 Genitography Uretrocystoscopy-colposcopy Diagnostic laparoscopy 
Sex chromosome DSD 2 6 6 
46XY DSD - - 1 
46 XX DSD 1 6 2
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feminizing genitoplasty, and gonadectomy. In table 
7, we can see the type and number of therapeutic 
management commonly performed by urologists 
except in the two cases of vaginal agenesis, which 
was performed by an obstetrics gynecologist.
Table 6. Gender assignment.
Table 7. Therapeutic management of DSD.
DISCUSSION
Congenital adrenal hyperplasia (CAH) is the 
7-9most common DSD in several reports.  In fact, a 
study reported the frequency of CAH of as high as 
872%.  The next most common DSD is androgen 
Gender Assignment 
Male Female Not decided yet Total 
Sex chromosome DSD 2 21 1 24
46XYDSD 16 6 2 24
46XXDSD 0 82 8 80
Type 
Not yet underwent full workup N/A N/A 5 5
Total 18 109 16 133
Type DSD Therapeutic Management Freq
Turner syndrome Medication only 15 
Clitoroplasty 2 
Sex chromosome 
DSD Mixed gonadal dysgenesis 
Clitorovaginoplasty + laparascopy gonadectomy  2 
  Hypospadia repair 1 
  None has been taken 4 
46XY DSD Gonadal dysgenesis  None has been taken 1 
 AIS Clitorovaginoplasty + laparascopy gonadectomy 1 
  Hipospadia repair 2 
  Hipospadia repair + orkidopecxy 1 
  None has been taken 13 
 Hipospadia repair 3 
 
Defisiensi 5-a reduktase  
Plan to do hipospadia repair 1 
 Aphalia Phalloplasty 1 
46 XX DSD Ovotesticular Clitorovaginoplasty + laparascopy gonadectomy 1 
  None has been taken 2 
 CAH Clitoroplasty 15 
  Clitorovaginoplasty 5 
  Plan to do clitoroplasty/clitorovaginoplasty 7 
  Medication only 48 
Vaginal atresia Vaginoplasty 2
9insensitivity syndrome (AIS).  We found similar 
result in our study. CAH is the most common DSD, 
contributing as high as 56,4% of all cases, followed 
AIS as the second most common DSD represents 
13,5% of all DSD cases.
The patient's age at diagnosis is varied. If 
ambiguous genitalia are evident, most patients can be 
diagnosed when they are still neonates or toddlers. 
However, the DSD cases can also be diagnosed 
initially in older age groups. Usually, the presence of 
unrecognized or belatedly recognized ambiguous 
genitalia, the presence of hernia in girls, delayed 
puberty, and virilization for girls, primary 
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amenorrhea, and the absence of breast development 
10in girls are responsible for the delayed diagnosis.  
In this study, 48% of the cases was diagnosed when 
the patient is under 1 year old, 20% during 
toddlerhood, 8% during prepubertal period, and 
23% during the pubertal period. CAH was the most 
common DSD observed in infants under the age of 1 
year (78%). These findings similar with a number of 
other reports. The Rajendran report in 1995 
observed the same findings, 86% of DSD cases were 
diagnosed in toddler period and 8,5% during 
11pubertal period.  A report conducted by Joshi 
(2006) in 109 patients found that 57,8% cases were 
9diagnosed during the first year of the patient's life.  
These findings shows that the understanding and 
early detection of DSD cases in the multidiscipli-
nary team in RSCM is similar to the institutions 
abroad.
Considering the sex of rearing, we can see that 
most of the DSD sex chromosome and 46 XX DSD 
are raised as girls (respectively 92% and 83%) while 
the 46XY DSD are raised as boys (61%). On the 
gender assignment, all of 46 XX DSD decided to 
become female, while gender assignment result for 
46 XY DSD and sex chromosome DSD are varied. 
The management of DSD poses its own 
challenges. Establishing a diagnosis or the type of 
DSD, gender assessment, and surgical or 
pharmacological therapy are still considered 
controversial issues. Therefore, the management of 
DSD requires a multidisciplinary approach. The 
team should consist of endocrinologist, urologist, 
anesthesiologist, geneticist, obstetrics gynecologist 
6and psychiatrist.  
The urologist should always be a central 
member of the multidisciplinary team and usually 
becomes a first line consultant, especially in an 
4institution without a DSD multidisciplinary team.  
The urologist plays a role in the diagnostic and 
therapeutic management. The diagnostic 
management that can be performed by the urologist 
include anamnesis, physical examination when the 
patient is anaesthetized, imaging by ultrasono-
graphy and genitography, uretrocystoscopy, and 
6laparoscopy.  The therapeutic management that can 
be conducted by the urologist are masculinizing 
surgery, feminizing surgery, and gonadectomy.
Physical examination under anaesthesia is 
required because the patients are commonly still 
very young so that a complete physical examination 
without anaeshthesia would be very difficult. 
Physical examination is necessary to evaluate the 
morphology of the external genitalia, such as the 
shape and size of phallus, the shape and color of the 
labioscrotal fold, the presence of gonads and 
accompanying abnormalities such as urogenital 
sinus.
Genitography is performed to evaluate the 
shape and abnormalities of the vagina and the 
presence of urogenital sinus and its classification. 
Uretrocystoscopy and colposcopy are performed to 
confirm the anatomical results of genitography, to 
verify the uterus portio, to visualize the type of 
urogenital sinus and its position regarding the 
12introitus and bladder neck.  The type of urogenital 
sinus and its position regarding introitus and 
bladder neck is very important to determine the 
13type of reconstructive surgery.  In this study, from 
the 12 uretrocystoscopy-colposcopy procedures 
performed, we found some type 1 high-confluence 
urogenital sinus and type 11 low-confluence 
urogenital sinus on the 46XX DSD and sex 
chromosome DSD group.
Diagnostic laparoscopy is performed to 
confirm the presence of non palpable gonads and 
the presence of Mullerian structure and to perform 
12a biopsy of the gonad structure.  According to 
Medonca (2001), only the ovotesticular and sex 
chromosome DSD groups require diagnostic 
14laparoscopy to support the diagnosis.  In this study, 
9 diagnostic laparoscopy procedures were 
perfomed, 2 of which to the ovotesticular type 
patients, 6 to the sex chromosome DSD patients, 
and 1 to the AIS parients. From these 9 procedures, 
3 cases of testes with gonad streak, 1 case of ovaries 
and testes, 2 cases of ovotestes, and 1 case of 
prepubertal testes with gonadoblastoma testicular 
dysplasia were found.
After the diagnostic management are 
completed, including anamnesis all the way to 
workup studies, a gender assignment involving the 
patient and the family is conducted by the 
multidisciplinary team. Complete diagnostic 
management are necessary before the gender 
assignment is conducted. One of the important 
diagnostic management is gonad biopsy during 
laparoscopy/laparotomy. In this study, 1 MGD case 
was managed by diagnostic laparotomy without 
gonad biopsy, proceded with female gender 
assignment and clitoroplasty. However, apparently 
the presence of testes was still suspected during 
evaluation. After a diagnostic laparoscopy with 
biopsy was performed, the biopsy specimen shows 
prepubertal testes. The patient then underwent 
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regender assignment, and was decided to still be a 
female and to undergo gonadectomy.
The therapeutic management are conducted after 
gender assignment. One of the therapeutic 
management is surgery. The purpose of surgery is to 
restore the anatomy and function of genitalia and to 
4eliminate the possibility of gonadal malignancy.  The 
15ideal time for surgery is still a controversial topic.
Masculinizing surgery is generally more 
complex and requires more than one surgical 
4procedures.  The usual procedures conducted in this 
surgery are chordae release, urethral reconstruction, 
5and testosterone supplementation.  These surgical 
procedures should be conducted at early age to 
prevent the potential psychosexual and social 
16problems to the patient and the family.  Chertin 
(2005) reported that masculinizing surgery 
procedures for children with an average age of 1,8 
16years old result in good outcomes.  While Denes 
(2009) reported the similar approach to the patient 
with older average ages of 8,6 + 9,8 years old, but the 
better cosmetic outcome and fewer complications is 
17found in the age group of under 2 years old.  In this 
research, there were several masculinizing surgeries 
conducted, including one phalloplasty, one 
hipospadia repair and orchidopexy, 6 hipospadia 
repair, and there was one planned hypospadia repair. 
Regarding the age during surgery, the majority of 
surgeries (62%) were conducted during toddlerhood, 
and the rest (38%) were during teenage period. In this 
research, there were cases of 5-alpha-reductase 
deficiency which required a dehydrotestosterone 
hormonal supplementation. However, the supply of 
such supplementation is not available in Indonesia 
and the postoperative phallus size remains 
undersized.
The procedures in feminizing surgery include 
the reconstruction of external genitalia, exteorization 
of vagina, and urogenital sinus repair. Normally, a 
5refinement surgery is needed during puberty.  The 
patients' age during surgery also remains 
controversial. Ahmad Al Dassaoukay (2009) 
conducted feminizing surgeries to patients aged 6 
18months to 9 years old.  There were 15 clitoroplasty, 8 
clitorovaginoplasty, 2 vaginoplasty, and 6 plans of 
clitoroplasty ot clitorovaginoplasty. Regarding the 
age during surgery, the majority (83%) of surgeries 
was conducted in the toddlerhood and the rest (17%) 
were conducted during pubertal period.
The type of germinal tumor in DSD are 
seminoma (testicular) or disgerminoma (ovaries) 
19and non-seminoma.  The development of these 
tumor is almost always preceeded by an in situ 
neoplastic lesion (intratubular germ cell neoplasia 
20unclassified (ITGNU) or gonadoblastoma).  The 
incidence of germinal tumor in DSD are varies. The 
first study reporting the incidence of germ-cell tumor 
incidence in AIS was approximated at 22% and then 
19,20corrected to 5-10% in the further research.  
Regarding the type of DSD, the risk of gonadal 
transformation into malignancy is varied depending 
on some number of parameters, some of them have 
already been identified. The highest risk was found in 
the group of gonadal dysgenesis (12-35%) and PAIS 
group with non-palpable gonad (20-30%). The 
lowest risk is found in CAIS and ovotesticular group 
15,19(2,3%).  In contrast to the AIS group, the age 
during the incidence of germinal tumor in gonadal 
dygenesis group is generally earlier, since birth until 
19the first year.  Gonadectomy is recommended in the 
15high risk groups.  In this research, 4 laparoscopic 
gonadectomy was performed with 50% of the 
surgery was performed for MGD patients, 25% for 
AIS, and 25% for ovotesticular DSD. From anato-
mical pathology examination, one case of testes with 
gonadoblastoma testicular dysplasia was reported. 
No germinal tumour ever reported.
The outcome of the management of DSD, 
including the surgical management which can be 
evaluated in both short and long term, includes the 
anatomic cosmetic appearance, and sexual function. 
In this research, the data regarding the evaluation of 
DSD management is still unobtainable. Some studies 
which were conducted abroad reported diverse 
outcomes.
Sircilli (2010) reported that masculinizing 
surgery satisfied 85% of the patiens, but the 
complaints about the size of penis, sexual activity 
21and urinary problems is not uncommon.  Denes' 
study (2009) reported that the anatomical shape 
which was cosmetically good was 42%, regular was 
55% and bad was 3%. The common surgical 
complication is urethrocutaneous fistula and urtheral 
stricture which commonly requires corrective 
17surgery.
The cosmetic and functional outcome of the 
feminizing surgery is associated with the type of 
18surgical procedures and the type of urogenital sinus.  
Denes (2009) reported that feminizing surgery 
perfomed on paients with CAH results in  good 
anatomical and functional results in 68% of the 
cases, and there were 21% surgical complication 
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including bleeding, glans necrosis and stenosis of the 
22vaginal introitus.  Ahmad Al Dassoukay (2009) 
reported other complications such as urinary 
18incontinence, besides the ones previously discussed.
CONCLUSION
The majority case on RSCM's DSD profile was 
CAH. The management of DSD has been conducted 
by multidisciplinary team. The profile management 
encompasses a thourough evaluation including 
anamnesis, physical examination, while the patient is 
anaesthetized, chromosome analysis, laboratory 
examination, radiologis imaging, and other additional 
management. The management is then preceeded by a 
gender assignment. The gender assignment is held by 
the multidisciplinary team, involves the patient and 
family. The urologist becomes important element of 
this team, regarding their role in diagnostic efforts, 
including physical examination with or without 
anaesthesia, uretrocystoscopy-colposcopy and 
diagnostic laparoscopy along with gonad biopsy. The 
diagnostic management, including the gonad biopsy, 
should be completed thoroughly before conducting a 
gender assignment. 
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